HK1039111A1 - Method for producing enantiomer-free n-methyl-n-Ä(1S)-1-phenyl-2-((3S)-3- hydroxypyrrolidine-1-yl) ethylÜ-2,2-diphenyl acetamide - Google Patents

Method for producing enantiomer-free n-methyl-n-Ä(1S)-1-phenyl-2-((3S)-3- hydroxypyrrolidine-1-yl) ethylÜ-2,2-diphenyl acetamide

Info

Publication number
HK1039111A1
HK1039111A1 HK01107952A HK01107952A HK1039111A1 HK 1039111 A1 HK1039111 A1 HK 1039111A1 HK 01107952 A HK01107952 A HK 01107952A HK 01107952 A HK01107952 A HK 01107952A HK 1039111 A1 HK1039111 A1 HK 1039111A1
Authority
HK
Hong Kong
Prior art keywords
methyl
phenyl
hydroxypyrrolidino
formula
derivative
Prior art date
Application number
HK01107952A
Other languages
Unknown language ( )
English (en)
Inventor
Karl-August Ackermann
Inge Stein
Rudolf Gottschlich
Bernd Helfert
Andreas Bathe
Jens Budak
Original Assignee
Tioga Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7865063&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1039111(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tioga Pharmaceuticals Inc filed Critical Tioga Pharmaceuticals Inc
Publication of HK1039111A1 publication Critical patent/HK1039111A1/

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B35/00—Reactions without formation or introduction of functional groups containing hetero atoms, involving a change in the type of bonding between two carbon atoms already directly linked
    • C07B35/02—Reduction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B43/00—Formation or introduction of functional groups containing nitrogen
    • C07B43/06—Formation or introduction of functional groups containing nitrogen of amide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK01107952A 1998-04-20 2001-11-12 Method for producing enantiomer-free n-methyl-n-Ä(1S)-1-phenyl-2-((3S)-3- hydroxypyrrolidine-1-yl) ethylÜ-2,2-diphenyl acetamide HK1039111A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19817393 1998-04-20
DE19827633A DE19827633A1 (de) 1998-04-20 1998-06-20 Verfahren zur Herstellung von enantiomerenreinem N-Methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamid
PCT/EP1999/002574 WO1999054298A1 (de) 1998-04-20 1999-04-16 Verfahren zur herstellung von enantiomerenreinem n-methyl- n-[(1s)- 1-phenyl- 2-((3s)-3- hydroxypyrrolidin- 1-yl)ethyl]- 2,2- diphenylacetamid

Publications (1)

Publication Number Publication Date
HK1039111A1 true HK1039111A1 (en) 2002-04-12

Family

ID=7865063

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01107952A HK1039111A1 (en) 1998-04-20 2001-11-12 Method for producing enantiomer-free n-methyl-n-Ä(1S)-1-phenyl-2-((3S)-3- hydroxypyrrolidine-1-yl) ethylÜ-2,2-diphenyl acetamide

Country Status (28)

Country Link
US (1) US6344566B1 (da)
EP (2) EP1607090B1 (da)
JP (1) JP4688292B2 (da)
KR (1) KR100649175B1 (da)
CN (2) CN1846696A (da)
AR (2) AR019080A1 (da)
AT (2) ATE303361T1 (da)
AU (2) AU761721B2 (da)
BR (1) BR9909731A (da)
CA (1) CA2329210C (da)
CY (1) CY1112314T1 (da)
CZ (1) CZ301121B6 (da)
DE (2) DE19827633A1 (da)
DK (2) DK1073634T3 (da)
ES (2) ES2375384T3 (da)
HK (1) HK1039111A1 (da)
HU (1) HUP0101600A3 (da)
MY (1) MY120471A (da)
NO (1) NO317984B1 (da)
PL (1) PL206969B1 (da)
PT (1) PT1607090E (da)
RU (1) RU2298549C2 (da)
SI (2) SI1073634T1 (da)
SK (2) SK286442B6 (da)
TW (1) TWI249524B (da)
UA (1) UA73472C2 (da)
WO (1) WO1999054298A1 (da)
ZA (1) ZA200006689B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10259245A1 (de) * 2002-12-17 2004-07-01 Merck Patent Gmbh Derivate des Asimadolins mit kovalent gebundenen Säuren
EP1680115A1 (en) * 2003-10-30 2006-07-19 Tioga Pharmaceuticals, Inc. Use of selective opiate receptor modulators in the treatment of neuropathy
US20070160559A1 (en) * 2006-01-12 2007-07-12 Roszell James A Skin disinfectant composition and methods for using
CN101677997B (zh) * 2007-03-30 2012-05-09 泰奥加制药公司 用于治疗腹泻型和交替型肠易激综合征的κ-阿片剂激动剂
CN103664727A (zh) * 2013-12-19 2014-03-26 无锡万全医药技术有限公司 一种一锅法制备1-[(3s)-3-羟基吡咯烷-1-基]-(2s)-2-甲氨基-2-苯基乙烷的工艺
CN103772257A (zh) * 2013-12-31 2014-05-07 无锡万全医药技术有限公司 一种制备2-((3s)-3-羟基吡咯烷-1-基)-(1s)-1-苯乙基氨基甲酸酯的方法
WO2016161085A1 (en) 2015-04-01 2016-10-06 Cedars-Sinai Medical Center Anti-methanogenic lovastatin analogs or derivatives and uses thereof
CN112574068A (zh) * 2020-11-17 2021-03-30 万华化学（宁波）有限公司 一种低色号高稳定性碳化二亚胺改性异氰酸酯的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232978A (en) * 1988-12-23 1993-08-03 Merck Patent Gesellschaft Mit Beschrankter Haftung 1-(2-arylethyl)-pyrrolidines
DE4034785A1 (de) * 1990-11-02 1992-05-07 Merck Patent Gmbh 1-(2-arylethyl)-pyrrolidine
DE4215213A1 (de) * 1992-05-09 1993-11-11 Merck Patent Gmbh Arylacetamide
DE4425071C2 (de) * 1994-07-15 1996-08-29 Degussa Verfahren zur Herstellung optisch aktiver Pyrrolidine mit hoher Enantiomerenreinheit
DE19523502A1 (de) * 1995-06-28 1997-01-02 Merck Patent Gmbh Kappa-Opiatagonisten für entzündliche Darmerkrankungen
DE19531464A1 (de) * 1995-08-26 1997-02-27 Merck Patent Gmbh N-Methyl-N-[(1S-)-1-phenyl-2-((3S)-3-hydroxypyrrolidin 1-yl-)-ethyl]-2,2-diphenyl-acetamid
WO1998003491A1 (en) * 1996-07-24 1998-01-29 Warner-Lambert Company Diphenyl-cyclopropenes as selective k-agonists
DE19647538A1 (de) * 1996-11-16 1998-05-20 Merck Patent Gmbh Verfahren zur Herstellung von enantiomerenreinem N-Methyl-N-[1-phenyl-2-(-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamid

Also Published As

Publication number Publication date
DE19827633A1 (de) 1999-10-21
ES2375384T3 (es) 2012-02-29
HUP0101600A2 (hu) 2001-09-28
AU2003248428A1 (en) 2003-11-06
HUP0101600A3 (en) 2002-12-28
AR019080A1 (es) 2001-12-26
AU2003248428B2 (en) 2005-10-20
NO317984B1 (no) 2005-01-17
EP1073634A1 (de) 2001-02-07
ATE303361T1 (de) 2005-09-15
AU761721B2 (en) 2003-06-05
EP1073634B1 (de) 2005-08-31
NO20005259D0 (no) 2000-10-19
SI1073634T1 (sl) 2006-02-28
DK1073634T3 (da) 2006-01-09
SI1607090T1 (sl) 2012-01-31
CN1310884C (zh) 2007-04-18
NO20005259L (no) 2000-10-19
PT1607090E (pt) 2012-01-10
DE59912502D1 (de) 2005-10-06
TWI249524B (en) 2006-02-21
CN1846696A (zh) 2006-10-18
CZ20003860A3 (cs) 2001-01-17
US6344566B1 (en) 2002-02-05
CN1297435A (zh) 2001-05-30
ES2251194T3 (es) 2006-04-16
CA2329210A1 (en) 1999-10-28
PL343556A1 (en) 2001-08-27
CY1112314T1 (el) 2015-12-09
SK286442B6 (sk) 2008-10-07
MY120471A (en) 2005-10-31
WO1999054298A1 (de) 1999-10-28
CZ301121B6 (cs) 2009-11-11
CA2329210C (en) 2008-03-04
SK288016B6 (sk) 2012-11-05
AU4031199A (en) 1999-11-08
UA73472C2 (en) 2005-08-15
KR20010042750A (ko) 2001-05-25
DK1607090T3 (da) 2012-01-30
JP4688292B2 (ja) 2011-05-25
KR100649175B1 (ko) 2006-11-24
PL206969B1 (pl) 2010-10-29
EP1607090A1 (de) 2005-12-21
SK15572000A3 (sk) 2001-05-10
ZA200006689B (en) 2002-02-18
EP1607090B1 (de) 2011-10-12
BR9909731A (pt) 2000-12-19
ATE527999T1 (de) 2011-10-15
AR066455A2 (es) 2009-08-19
JP2002512223A (ja) 2002-04-23
RU2298549C2 (ru) 2007-05-10

Similar Documents

Publication Publication Date Title
PT768309E (pt) Processo para a preparacao de compostos de imidazolilo enantiomericamente puros
US20100076204A1 (en) Process for the preparation of levetiracetam
HK1039111A1 (en) Method for producing enantiomer-free n-methyl-n-Ä(1S)-1-phenyl-2-((3S)-3- hydroxypyrrolidine-1-yl) ethylÜ-2,2-diphenyl acetamide
WO2003003804A3 (en) Process for the production of optically active 3-phenylisoserine
HUT54156A (en) Process for producing new n-heteroarylpurine-6-amine derivatives and pharmaceutical compositions comprising such compounds
EA200300804A1 (ru) Усовершенствованный способ получения карбапенема
CA2438854A1 (en) Method of preparing non-hydrated fexofenadine hydrochloride and novel crystalline form obtainable by this method
AU1289600A (en) Process for racemization
EP0983999B8 (en) Process for producing amide derivatives and intermediates
IL197970A (en) Process for making piperidinyl-sulfanyl-acetyl-motilines
MXPA01011104A (es) Procedimiento de sintesis de derivados n-(mercaptoail)-aminoacidos a partir de acidos acrilicos alfa substituidos.
IL108829A0 (en) Enzymatic resolution of alkyl 2-piperidinecarboxylates and use of the compounds obtained as synthesis intermediates
Westrum et al. A synthesis of enantiomerically pure 3-and 3, 3-disubstituted pyrrolidines
Suresh Babu et al. A Practical and Enantiospecific Synthesis of (−)‐(R)‐and (+)‐(S)‐Piperidin‐3‐ols
GEP20022679B (en) Process For The Synthesis Of Chloropurine Intermediates
WO2004099138A3 (en) Process for the preparation of perindopril
CA2170223A1 (en) [3-amino]-tetrahydrocarbazole-propanoic acid esters
JP3828197B2 (ja) 光学活性３−（ｐ−メトキシフェニル）グリシッド酸アルカリ金属塩の製造法
ZA969534B (en) Preparation of chiral pyrrolidinone derivatives
HUP0002449A2 (hu) Eljárás 3-fluoroxindol-származékok előállítására és az eljárásban alkalmazott intermedierek
TH48781A3 (th) กระบวนการสำหรับการเตรียม n-เมธิล-n-(1s)-1-ฟีนิล-2((3s)-3-ไฮดรอกซีพิร์โรลิดีน-1-อิล)เอธิล]-2,2-ไดฟีนิลอะเซตทาไมด์ที่มีความบริสุทธิ์ในเชิงอิแนนชิโอเมอร์
Miyata et al. Stereospecific addition of thiophenol to electron-deficient double bond and its application to natural product synthesis
KR970010172B1 (en) (2s, 3as, 7as)-2-(hydroxymethyl) octahydroindole, its process for the manufacture use for synthesis of(s) -secondary alcohal
MX9701992A (es) Procedimiento para preparar compuestos de trans-3-fenilglicidamida opticamente activos.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150416